Health Industry

Latest California Healthline Stories

Heartbeat-Tracking Technology Raises Patients’ and Doctors’ Worries

As Google joins Apple in adding heart rhythm sensors to wearable devices, and millions of people gain access to alerts that flag when their hearts might have skipped a beat, cardiologists are wondering what to do with all the information.

Why Cheap, Older Drugs That Might Treat Covid Never Get Out of the Lab

The hydroxychloroquine and ivermectin fiascoes have soured many doctors on repurposing drugs for covid. A few inexpensive old drugs may be as good as some of the new antivirals, but they face complex obstacles to get to patients.

Battle Lines Are Drawn Over California Deal With Kaiser Permanente

A controversial proposal to grant HMO giant Kaiser Permanente a no-bid statewide Medi-Cal contract is headed for its first legislative hearing amid vocal opposition from a coalition of counties, competing health plans, community clinics, and a national health care labor union.

KHN’s ‘What the Health?’: News You Might Have Missed

Congress is in recess, so the slower-than-average news week gives us a chance to catch up on underreported topics, like Medicare’s coverage decision for the controversial Alzheimer’s disease drug Aduhelm and ominous new statistics on drug overdose deaths and sexually transmitted diseases. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.

It’s Not Just Physicians and Nurses. Veterinarians Are Burning Out, Too.

Empathy overload and compassion fatigue contribute to the mental health woes of veterinarians, who are more likely than other Americans to attempt suicide. And with 23 million families adopting pets during the pandemic, vets’ stress burden is no doubt heavier now.

California Handed Its Medicaid Drug Program to One Company. Then Came a Corporate Takeover.

The company awarded the state’s Medi-Cal Rx contract was taken over by another company, Centene. That left the state with a contractor it didn’t pick — one that has been accused of overbilling nine other state Medicaid programs and is now under investigation by California.